Fighting Flu
October 25, 2016
Can bioinformatics point the way towards a universal flu vaccine?
1 min read

October 25, 2016
Can bioinformatics point the way towards a universal flu vaccine?
1 min read
October 25, 2016
Steve Keen talks to us about Trump, China, free trade and globalization
1 min read
October 20, 2016
Conventional formulation tactics do not work for all drugs, but more complex solutions, such as liposomes and microparticles, are giving rise to new opportunities in drug delivery and drug targeting. In this roundtable, experts discuss the trends and challenges in the development and manufacture of complex dosage forms.
1 min read
October 20, 2016
A thorough understanding of your process and how it impacts your product’s critical quality attributes is essential for decision-making, development and scale up. Are you up-to-date with new analytical platforms that can give you the edge?
1 min read
October 20, 2016
The players and chips are ready, and cards are being closely guarded; what can poker teach us about the biosimilars business?
1 min read
October 20, 2016
As big pharma looks to snap up an increasing number of successful orphan drug firms, CEOs should be wary because orphans are usually better off alone.
1 min read
October 20, 2016
Cell therapy successes have got the industry talking, but the future of the field now lies in the hands of manufacturing specialists who must develop factories capable of meeting high demands.
1 min read
October 20, 2016
Sitting Down With... Carol Lynch, Global Head of Biopharmaceuticals, Sandoz, and Chair of the Biosimilar Medicines Group, a sector group of Medicines for Europe.
1 min read
October 20, 2016
Development of a universal flu vaccine is not impossible for the industry – we just need bioinformatics to show us the way forward.
1 min read
October 20, 2016
Tablets are still the most common dosage form, but today’s consumers tend to have strong preferences and expect the freedom of choice. Have you considered all of your options?
1 min read
False
False